This personalized approach reduces trial-and-error and improves the chance that your first medication regimen works well
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Will the flatulence go away on its own
For those already prone to delayed gastric emptying, Ozempic can exacerbate the condition
Foods to avoid or limit on a GLP-1 diet Just as there are foods to include, there are certain foods you should steer clear of